Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC7A6OS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RAD51D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APLP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM56 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UTP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAGED2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMED4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC374443 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CENPA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNKS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP128 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKR7A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP5J2-PTCD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
E2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDHD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MLYCD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on